Tag

Astellas Pharma India Private Limited

1 article

Astellas VYLOY Approved for Gastric Cancer India

Astellas Pharma India announced CDSCO approval of VYLOY (zolbetuximab) combined with chemotherapy for first‑line treatment of HER2‑negative, CLDN18.2‑positive gastric/GEJ adenocarcinoma. Phase 3 SPOTL